Unity Biotechnology, Inc.
UBX · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $8 | $9 | $8 |
| Short-Term Investments | $9 | $16 | $20 | $26 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $2 |
| Total Curr. Assets | $18 | $24 | $30 | $36 |
| Property Plant & Equip (Net) | $12 | $12 | $16 | $17 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $13 | $13 | $17 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $38 | $47 | $54 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $2 | $1 |
| Short-Term Debt | $4 | $0 | $4 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $2 | -$6 | $0 |
| Total Curr. Liab. | $9 | $9 | $9 | $9 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $2 | $4 | $3 |
| Total NC Liab. | $21 | $22 | $24 | $25 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $19 | $24 | $21 | $22 |
| Total Liabilities | $31 | $31 | $33 | $34 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$518 | -$510 | -$502 | -$495 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$0 | $6 | $14 | $20 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30 | $38 | $47 | $54 |
| Net Debt | -$4 | -$8 | -$5 | -$8 |